DrugCite
Search

ERYTHROMYCIN BASE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Erythromycin Base Adverse Events Reported to the FDA Over Time

How are Erythromycin Base adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Erythromycin Base, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Erythromycin Base is flagged as the suspect drug causing the adverse event.

Most Common Erythromycin Base Adverse Events Reported to the FDA

What are the most common Erythromycin Base adverse events reported to the FDA?

Rash
31 (4.93%)
Nausea
22 (3.5%)
Vomiting
18 (2.86%)
Dyspnoea
13 (2.07%)
Drug Interaction
11 (1.75%)
Abdominal Pain Upper
9 (1.43%)
Hypersensitivity
9 (1.43%)
Malaise
9 (1.43%)
Diarrhoea
8 (1.27%)
Urticaria
8 (1.27%)
Rhabdomyolysis
7 (1.11%)
Show More Show More
Fatigue
6 (.95%)
Hepatic Enzyme Increased
6 (.95%)
Hypotension
6 (.95%)
Oedema Peripheral
6 (.95%)
Paraesthesia
6 (.95%)
Pruritus
6 (.95%)
Abdominal Discomfort
5 (.79%)
Back Pain
5 (.79%)
Cholestasis
5 (.79%)
Cough
5 (.79%)
Drug Ineffective
5 (.79%)
Pyrexia
5 (.79%)
Renal Failure Acute
5 (.79%)
Sepsis
5 (.79%)
Swelling Face
5 (.79%)
Abdominal Distension
4 (.64%)
Abdominal Pain
4 (.64%)
Arthritis
4 (.64%)
Confusional State
4 (.64%)
Drug Dispensing Error
4 (.64%)
Jaundice Cholestatic
4 (.64%)
Rash Erythematous
4 (.64%)
Rotator Cuff Syndrome
4 (.64%)
Skin Disorder
4 (.64%)
Swelling
4 (.64%)
Syncope
4 (.64%)
Acarodermatitis
3 (.48%)
Anorexia
3 (.48%)
Ascites
3 (.48%)
Asthenia
3 (.48%)
Bacterial Infection
3 (.48%)
Bile Duct Stone
3 (.48%)
Blood Creatine Phosphokinase Increa...
3 (.48%)
Cellulitis
3 (.48%)
Constipation
3 (.48%)
Drug Toxicity
3 (.48%)
Dry Mouth
3 (.48%)
Electrocardiogram Qt Prolonged
3 (.48%)
Goitre
3 (.48%)
Haematemesis
3 (.48%)
Hepatic Failure
3 (.48%)
Hepatic Steatosis
3 (.48%)
Hepatitis
3 (.48%)
Hyperhidrosis
3 (.48%)
Hypertriglyceridaemia
3 (.48%)
Hypoacusis
3 (.48%)
Hyponatraemia
3 (.48%)
Influenza Like Illness
3 (.48%)
Jaundice
3 (.48%)
Liver Disorder
3 (.48%)
Lobar Pneumonia
3 (.48%)
Muscle Spasms
3 (.48%)
Myalgia
3 (.48%)
Ocular Icterus
3 (.48%)
Palpitations
3 (.48%)
Pancreatitis
3 (.48%)
Productive Cough
3 (.48%)
Prothrombin Time Prolonged
3 (.48%)
Renal Failure
3 (.48%)
Sensory Loss
3 (.48%)
Small Intestinal Obstruction
3 (.48%)
Somnolence
3 (.48%)
Splenomegaly
3 (.48%)
Sputum Discoloured
3 (.48%)
Subclavian Vein Thrombosis
3 (.48%)
Unevaluable Event
3 (.48%)
Vision Blurred
3 (.48%)
Wheezing
3 (.48%)
White Blood Cell Count Increased
3 (.48%)
Adverse Drug Reaction
2 (.32%)
Anticonvulsant Drug Level Increased
2 (.32%)
Aphonia
2 (.32%)
Blister
2 (.32%)
Blood Magnesium Decreased
2 (.32%)
Bronchitis
2 (.32%)
C-reactive Protein Increased
2 (.32%)
Cardiac Arrest
2 (.32%)
Chest Discomfort
2 (.32%)
Chills
2 (.32%)
Chronic Obstructive Pulmonary Disea...
2 (.32%)
Colitis
2 (.32%)
Costochondritis
2 (.32%)
Deafness
2 (.32%)
Deafness Bilateral
2 (.32%)
Diabetic Coma
2 (.32%)
Diarrhoea Haemorrhagic
2 (.32%)
Dizziness
2 (.32%)
Drug Administration Error
2 (.32%)
Drug Exposure During Pregnancy
2 (.32%)
Drug Hypersensitivity
2 (.32%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Erythromycin Base, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Erythromycin Base is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Erythromycin Base

What are the most common Erythromycin Base adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Erythromycin Base, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Erythromycin Base is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Erythromycin Base According to Those Reporting Adverse Events

Why are people taking Erythromycin Base, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
87
Infection
20
Product Used For Unknown Indication
20
Lower Respiratory Tract Infection
10
Bronchitis
7
Acne
6
Show More Show More
Ear Infection
6
Pneumonia
5
Rosacea
5
Sinusitis
5
Cellulitis
3
Pharyngitis Streptococcal
3
Premature Rupture Of Membranes
3
Skin Infection
3
Wound
2
Upper Respiratory Tract Infection
2
Tooth Infection
2
Drug Exposure During Pregnancy
2
Antibiotic Prophylaxis
2
Viral Infection
2
Impaired Gastric Emptying
2
Prophylaxis
2
Infectious Mononucleosis
1
Skin Laceration
1
Impetigo
1
Gastric Hypomotility
1
Pyrexia
1
Tooth Abscess
1
Cystocele
1
Rash
1
Staphylococcal Infection
1
Urinary Tract Infection
1
Oropharyngeal Pain
1
Eczema
1
Confusional State
1
Dental Cleaning
1
Dermatitis Contact
1
Gingival Abscess
1
Skin Ulcer
1
Cough
1
Eczema Infected
1
Wound Infection
1
Abscess
1
Dental Disorder Prophylaxis
1
Skin Disorder
1
Influenza
1
Cardiac Murmur
1
Asthma
1
Sinus Disorder
1
Surgery
1
Gastric Disorder
1

Drug Labels

LabelLabelerEffective
Erythromycin Base FilmtabRebel Distributors Corp20-DEC-10
Erythromycin Base FilmtabCardinal Health08-SEP-11
Erythromycin Base FilmtabLake Erie Medical & Surgical Supply DBA Quality Care Products LLC12-MAR-12
Erythromycin BasePD-Rx Pharmaceuticals, Inc.04-MAY-12
Erythromycin Base BasePD-Rx Pharmaceuticals, Inc.04-MAY-12
Erythromycin Base FilmtabAbbott Laboratories16-JUL-12
Erythromycin BaseArbor Pharmaceuticals, Inc.18-MAR-13

Erythromycin Base Case Reports

What Erythromycin Base safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Erythromycin Base. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Erythromycin Base.